Letter to the Editor: Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Medicine.

This Letter to the Editor is in response to an article by Iba et al. (Coagulopathy of Coronavirus Disease 2019) and discusses dosing recommendations of low molecular weight heparin.

Added 7/27/20

Authors:
Piagnerelli, Michaël MD, PhD
Cauchie, Philippe MD
Wautrecht, Jean-Claude MD

Estimated Time: 02:00 min